Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile
Satoshi Tateshima, MD, DMSc

@stateshimamd

Professor UCLA Interventional Neuroradiology, CNS Endovascular Surgery. Inventor, Marathon Runner, Pilot. A samurai with wings. Tweets my own, ≠medical advice

ID: 1311148782923313152

linkhttps://profiles.ucla.edu/satoshi.tateshima calendar_today30-09-2020 03:40:12

517 Tweet

3,3K Followers

103 Following

BRAIN Conference (@brainconferenc1) 's Twitter Profile Photo

We love seeing your Christmas #BRAINConference photos!🎄📸 Don’t forget to share your festive snapshots on the Activity Feed in the BRAIN Conference app📱to spread the holiday cheer. 🎅🎁 We can’t wait to see pictures from tonight’s gala dinner! 🍽️🎉

We love seeing your Christmas #BRAINConference photos!🎄📸 Don’t forget to share your festive snapshots on the Activity Feed in the BRAIN Conference app📱to spread the holiday cheer. 🎅🎁 We can’t wait to see pictures from tonight’s gala dinner! 🍽️🎉
Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Acute LVO due to underlying ICAD is often unrecognized. Detection & switching to rescue therapy may improve the outcome. pubmed.ncbi.nlm.nih.gov/39106922/ pubmed.ncbi.nlm.nih.gov/38041666/ pubmed.ncbi.nlm.nih.gov/36681321/

Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Rapid Medical enrolls the first patient in COGNITIVE Study, the first to examine thrombectomy's impact on cognitive function. TIGERTRIEVER’s unique design may help preserve cognition. businesswire.com/news/home/2025…

NeuroNews (@nn_publishing) 's Twitter Profile Photo

.Rapid Medical has announced enrolment of the first patient in its COGNITIVE study—which, according to the company, is the first study to examine a link between mechanical #Thrombectomy and cognitive improvement Fawaz Al-Mufti, MD, FSVIN Satoshi Tateshima, MD, DMSc neuronewsinternational.com/rapid-medical-…

Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

We published TG dilator stent-plasty FIM cases in JNIS last year. What happened to patients who underwent conventional angioplasty w/wo stenting instead of TG dilator stent-plasty? Here is the summary. jnis.bmj.com/content/16/12/…

Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Enterprise stent showed less thrombus formation than other non-coated stents—yet the manufacturer doesn’t claim this as a feature. An overlooked benefit or intentional silence on anti-corrosive parylene coating on Enterprise? mdpi.com/2913504 #mdpibioengineering

Enterprise stent showed less thrombus formation than other non-coated stents—yet the manufacturer doesn’t claim this as a feature. An overlooked benefit or intentional silence on anti-corrosive parylene coating on Enterprise?  
mdpi.com/2913504 #mdpibioengineering
Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

We tracked how brain arteries change over time. ✅ Arteries lengthen & become tortuous over decades ✅ Factors such as hypertension & diabetes accelerate change ✅ Insights could refine stroke & aneurysm risk prediction. Research lead by Dr. Chien. sciencedirect.com/science/articl…

Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Encountered an aberrant right subclavian artery today—but instead of the usual retroesophageal course, this one passed anterior to both the trachea and esophagus. An extremely rare variant—seen in less than 5% of ARSA cases!

Encountered an aberrant right subclavian artery today—but instead of the usual retroesophageal course, this one passed anterior to both the trachea and esophagus. An extremely rare variant—seen in less than 5% of ARSA cases!
Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Did a transradial cerebral angio without knowing the patient had an aberrant right subclavian artery. Turned out to be a bovine arch and direct aortic origin of the left vertebral. Basically, a vascular version of a haunted house. Would not recommend!

Did a transradial cerebral angio without knowing the patient had an aberrant right subclavian artery. Turned out to be a bovine arch and direct aortic origin of the left vertebral. Basically, a vascular version of a haunted house. Would not recommend!
Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Happy to announce successful completion of patient enrollment in Japanese approval study for TG Dilator, a novel dual-layered stent-angioplasty device to treat intracranial atherosclerotic disease presenting with acute ischemic stroke due to large vessel occlusion.

Happy to announce successful completion of patient enrollment in Japanese approval study for TG Dilator, a novel dual-layered stent-angioplasty device to treat intracranial atherosclerotic disease presenting with acute ischemic stroke due to large vessel occlusion.
Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Press-release in NeuroNews . TG Medical completes patient enrolment in study evaluating novel ICAD stroke treatment neuronewsinternational.com/tg-medical-com…

Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Excited to share our latest work on Robotics in Neurointervention—just published in the 2025 Springer textbook Arterial Treatment of Neurological Diseases! Big thanks to Amir Molaie, Naoki Kaneko, Charles Beaman. Let’s keep pushing boundaries! #neurointervention #robotics

Excited to share our latest work on Robotics in Neurointervention—just published in the 2025 Springer textbook Arterial Treatment of Neurological Diseases! Big thanks to Amir Molaie, Naoki Kaneko, Charles Beaman. Let’s keep pushing boundaries! #neurointervention #robotics
Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Lt transverse sinus durla fistula with vein of Labbe drains adjacent to the fistula site. Comaneci assisted Labbe protection during trans-arterial embo. Also Comaneci-17 assisted catheterization to a feeder. Complete embo preserving Labbe & affected transverse sinus.

Lt transverse sinus durla fistula with vein of Labbe drains adjacent to the fistula site. Comaneci assisted Labbe protection during trans-arterial embo. Also Comaneci-17 assisted catheterization to a feeder. Complete embo preserving Labbe & affected transverse sinus.
New York Neuroscience Research & Innovation Lab (@nyneuroendovasc) 's Twitter Profile Photo

Big thanks to Dr. Satoshi Tateshima, MD, DMSc from UCLA for breaking down the COGNITIVE trial. The Tigertriever isn't just a cool name - its changing stroke care as we know it. #NYSIN25 Register virtually!

Big thanks to Dr. <a href="/STateshimaMD/">Satoshi Tateshima, MD, DMSc</a> from UCLA for breaking down the COGNITIVE trial. The Tigertriever isn't just a cool name - its changing stroke care as we know it. #NYSIN25 

Register virtually!
Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Facial venous malformation, R side kept enlarging. An accidental MRA revealed an AVM in the R masseter shunting into the VM, raising venous pressure. Treatment strategy: → first AVM embolized completely. → Then direct sclerotherapy Lesson: Hidden AVMs can drive VM growth.

Facial venous malformation, R side kept enlarging. An accidental MRA revealed an AVM in the R masseter shunting into the VM, raising venous pressure. Treatment strategy: 
→ first AVM embolized completely. 
→ Then direct sclerotherapy Lesson: 
Hidden AVMs can drive VM growth.
Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Congratulations to our outstanding graduating fellows, Dr. Keiko Fukuda & Dr. Kate Peterson! After 2 yrs of dedication & excellence in neuro-intervention UCLA Interventional Neuroradiology, they’re ready to make their mark. No doubt their future will be bright—wishing them every success ahead!

Congratulations to our outstanding graduating fellows, Dr. Keiko Fukuda &amp; Dr. Kate Peterson! After 2 yrs of dedication &amp; excellence in neuro-intervention <a href="/UCLAStrokeINR/">UCLA Interventional Neuroradiology</a>, they’re ready to make their mark. No doubt their future will be bright—wishing them every success ahead!
Satoshi Tateshima, MD, DMSc (@stateshimamd) 's Twitter Profile Photo

Challenging cavernous dural fistula: no IPS access, tortuous SOV/facial veins. Drilled occluded IPS w/ 0.014 wire + microcath. First entering normal cav sinus., another attempt to arterialized sinus! Complete embo cure w coil/onyx. Fluoro time <40 min. Patient back to normal!

Challenging cavernous dural fistula: no IPS access, tortuous SOV/facial veins. Drilled occluded IPS w/ 0.014 wire + microcath. First entering normal cav sinus., another attempt to arterialized sinus! Complete embo cure w coil/onyx. Fluoro time &lt;40 min. Patient back to normal!